Human mesenchymal stem cell products are superior to VEGF alone in in vivo angiogenesis

Journal article

Peer reviewed

Amir Najafi, Nima Aghili, Hajra Nashin, Xinzhi Peng, Roberta Lassance, Mary Susan Burnett, Stephen Epstein and Roberta Marques Lassance Soares

Cardiovascular revascularization medicine, Vol.11(3), pp.199-199

2010-07

Metrics

9 Record Views

Title: Human mesenchymal stem cell products are superior to VEGF alone in in vivo angiogenesis
Creators: Amir Najafi - MedStar Research Institute, Washington, DC, USA
Nima Aghili - MedStar Research Institute, Washington, DC, USA
Hajra Nashin - MedStar Research Institute, Washington, DC, USA
Xinzhi Peng - MedStar Research Institute, Washington, DC, USA
Roberta Lassance - MedStar Research Institute, Washington, DC, USA
Mary Susan Burnett - MedStar Research Institute, Washington, DC, USA
Stephen Epstein - MedStar Research Institute, Washington, DC, USA
Roberta Marques Lassance Soares - UMMG Department of Surgery
Publication Details: Cardiovascular revascularization medicine, Vol.11(3), pp.199-199
Academic Unit: Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Vascular & Endovascular Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031713747802976